Open science has been at the heart of the fight-back against the virus. As other crises loom, this underlines the need for governments to avoid protectionist moves and foster collaborative international research
Amid pressure to speed up vaccination programmes some member states are starting to go their own way on securing doses. The EU’s head vaccine official says no country can jump the queue
The pandemic has both spurred on and demonstrated the value of open science, but has also exposed gaps in science policy. Now is a good time for reform, says OECD
Simultaneous analysis of millions of individual cells could revolutionise treatments of cancer and cardiovascular, neurological, inflammatory and infectious diseases.
As UK looks about to lose its place in virtual European clinical networks, Cambridge University geneticist says ‘this isn’t some nebulous thing’ - a disease might only affect 50 people in the UK, but the top expert may be in Amsterdam
Lessons of the pandemic loom large in EU’s pharmaceutical strategy. ‘Never again do we want to see the problems we faced in the first weeks of the crisis,’ says EU vice president Margaritis Schinas
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.